Skip to content
Announcement:

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Moving compounds to IND using predictive retina models

Date

June 19, 2024

Presented by

Newcells Biotech

During this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

Speakers:

  • Dr Lauren Black – Distinguished Scientist/Consultant – Charles River Laboratories
  • Dr Roxana Redis – Associate Science Director – Charles River Laboratories
  • Dr Valeria Chichagova – Director of Technology – Newcells Biotech

Watch the on demand from here

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

Get our latest updates straight to your inbox